Once the heat of the campaign dissipates, a majority in both parties will remain susceptible to their main argument that high prices are necessary to promote innovation.
The co-chairs of the Congressional Diabetes Caucus want to shake up how insulin manufacturers use rebates, setting a potential template for legislative action on drug pricing next year.
The FDA’s post-market medical device cybersecurity plans and procedures don’t go far enough to protect public health in the face of cyber-threats, according to an OIG audit. The FDA, in response, has agreed with the OIG’s recommendations.
The CMS wants to make a few dramatic changes to the way it audits Medicare Advantage plans for overpayments. That could leave insurers on the hook for billions of dollars.
The CMS finalized its plans to pay for remote patient monitoring. It also will increase Medicare payment for home health agencies by 2.2% for 2019, or $420 million.
The CMS on Wednesday gave Wisconsin permission to impose work requirements on beneficiaries. It’s the first state to receive a green light for the policy without expanding Medicaid. The agency rejected the state’s mandatory drug testing proposal.
Health plan design principles issued by a multistakeholder group that includes Aetna and the Cleveland Clinic stress the need for engaging consumers to improve health outcomes but don’t address the growing use of high deductibles.
Children’s hospitals could see their revenue dip if increased anti-immigration sentiment from the Trump administration causes an exodus from Medicaid. Chronically ill children on Medicaid primarily go to these facilities for their hospital stays.
SSM Health reached a settlement with pension plan participants legally challenging the non-for-profit corporation’s church plan status, according to court documents filed Monday in U.S. District Court in St. Louis.